statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investors eyeing a purchase of Vera Therapeutics Inc (VERA) shares, but cautious about paying the going market price of 38.14/share, might benefit from considering selling puts among the...

Commit To Buy Vera Therapeutics At $25, Earn 12.7% Annualized Using Options

72-week data of atacicept in IgAN accepted as a best-ranked abstract Analysis of impact of atacicept on hematuria in IgAN accepted as a focused oral presentation BRISBANE, Calif., April 02...

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vera Therapeutics (VERA Research Report), Tyra Bioscience (TYRA...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Vera Therapeutics reports FY23 EPS ($2.25) vs ($3.35) last year

Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatmentActively adding sites and...

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Over the last three days, A.I.dvisor has detected that VERA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Vera Therapeutics (VERA, $44.19) Aroon Indicator entered an Uptrend on March 12, 2024.

Vera Therapeutics (VERA, $43.15) Aroon Indicator entered an Uptrend on March 11, 2024.

Vera Therapeutics (VERA, $44.3) Aroon Indicator entered an Uptrend on March 08, 2024.

This indicator may be signaling that VERA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Vera Therapeutics (VERA, $43.3) entered Downtrend as Momentum indicator drops below 0 level on Mar 07, 2024

Vera Therapeutics (VERA, $43.3) Aroon Indicator entered an Uptrend on March 07, 2024.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Volume	1.08M
52-Wk High	$50.78
52-Wk Low	$7.10

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.55	--	--	N/A
Q4'23	-$0.50	--	--	N/A
Q3'23	-$0.52	-$0.45	13.24%	BEAT
Q2'23	-$0.65	-$0.46	29.59%	BEAT
Q1'23	-$0.57	-$0.80	-40.62%	MISSED

VERA Vera Therapeutics Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals